Back
Protara Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Buy
73
TARA
Protara Therapeutics
Last Price:
6.02
Seasonality Move:
16.58%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARA is experiencing slight selling pressure.
Protara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.86 | Buy |
| 20-day SMA: | 3.9 | Buy |
| 50-day SMA: | 2.85 | Buy |
| 200-day SMA: | 2.72 | Buy |
| 8-day EMA: | 5.61 | Buy |
| 20-day EMA: | 4.44 | Buy |
| 50-day EMA: | 3.32 | Buy |
| 200-day EMA: | 2.65 | Buy |
Protara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 74.3 | Buy |
| Chaikin Money Flow: | -118214 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 5.25) | Buy |
| Bollinger Bands (100): | (1.33 - 3.51) | Buy |
Protara Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protara Therapeutics Stock
Is Protara Therapeutics Stock a Buy?
- Protara Therapeutics share price is 5.98 while TARA 8-day simple moving average is 5.86, which is a Buy signal.
- The stock price of TARA is 5.98 while Protara Therapeutics 20-day SMA is 3.90, which makes it a Buy.
- Protara Therapeutics 50-day simple moving average is 2.85 while TARA share price is 5.98, making it a Buy technically.
- TARA stock price is 5.98 and Protara Therapeutics 200-day simple moving average is 2.72, creating a Buy signal.
TARA Technical Analysis vs Fundamental Analysis
Buy
73
Protara Therapeutics (TARA)
is a Buy
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a Buy
The current Protara Therapeutics [TARA] share price is $5.98. The Score for TARA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Protara Therapeutics Stock Info
Market Cap:
123.37M
Price in USD:
5.98
Share Volume:
1.5M
Protara Therapeutics 52-Week Range
52-Week High:
10.48
52-Week Low:
1.46
Buy
73
Protara Therapeutics (TARA)
is a Buy
Protara Therapeutics Share Price Forecast
-
What is the Protara Therapeutics stock price today?
The Protara Therapeutics stock price is 5.98 USD today. -
Will TARA stock go up or go down?
Protara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protara Therapeutics is not overvalued.
Is Protara Therapeutics Stock a Buy?
- Protara Therapeutics share price is 5.98 while TARA 8-day exponential moving average is 5.61, which is a Buy signal.
- The stock price of TARA is 5.98 while Protara Therapeutics 20-day EMA is 4.44, which makes it a Buy.
- Protara Therapeutics 50-day exponential moving average is 3.32 while TARA share price is 5.98, making it a Buy technically.
- TARA stock price is 5.98 and Protara Therapeutics 200-day simple moving average is 2.65, creating a Buy signal.
Fundamental Analysis of Protara Therapeutics
Is Protara Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Protara Therapeutics
Should I short Protara Therapeutics stock?
- TARA Moving Average Covergence Divergence (MACD) indicator is 1.05, suggesting Protara Therapeutics is a Buy
- Protara Therapeutics Relative Strength Index (RSI) is 74.3, which suggest Protara Therapeutics is overbought
- The Bollinger Bands (25) for Protara Therapeutics is (2.01 - 5.25), which suggest Protara Therapeutics is a Buy
- The Bollinger Bands (100) for Protara Therapeutics is (1.33 - 3.51), which suggest Protara Therapeutics is a Buy
* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.